Paroxetine in social phobia/social anxiety disorder: Randomised, double- blind, placebo-controlled study

British Journal of Psychiatry

Volumn 175, Issue AUG., 1999, Pages 120-126

  Baldwin, David ^a   Bobes, Julio ^b   Stein, Dan J ^c   Scharwächter, Ingebor ^d   Faure, Michel ^e  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSIDAD DE OVIEDO   (Spain)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d Praxis Scharwächter   (Germany)

^e UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE;

ADULT; AGED; ANXIETY NEUROSIS; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SOCIAL PHOBIA; SOMNOLENCE; SWEATING; VERTIGO;

EID: 0032773913     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.175.2.120     Document Type: Article

References (24)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington, DC: APA.
2. Ballenger, J. C., Davidson, J. R. T., Lecrubier, Y., et al (1998) Consensus statement on social anxiety disorder. Journal of Clinical Psychiatry, 59 (suppl. 17), 54-60.
3. Davidson, J. R. T. (1998) Pharmacotherapy of social anxiety disorder. Journal of Clinical Psychiatry, 59 (suppl. 17), 47-51.
4. _, Hughes, D. L., George, L. K., et al (1993) The epidemiology of social phobia. Findings from the Duke Epidemiologic Catchment Area study. Psychological Medicine, 23, 709-718.
5. Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology, pp. 217-222. Washington, DC: Department of Health, Education and Welfare.
6. Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of the Society of Clinical Psychology, 6, 278-296.
7. Katzelnick, D. J., Kobak, K. A., Greist, J. H., et al (1995) Sertraline for social phobia: a double-blind, placebo-controlled, crossover study. American Journal of Psychiatry, 152, 1368-1371.
8. Lecrubier, Y., Bakker, A., Dunbar, G., et al (1997) A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Acta Psychiatrica Scandinavica, 95, 145-152.
9. Liebowitz, M. R. (1987) Social phobia. Modern Problems in Pharmacopsychiatry, 22, 141-173.
10. Magee, W. J., Eaton, W. W., Wittchen, H.-U., et al (1996) Agoraphobia, simple phobia and social phobia in the National Comorbidity Survey. Archives of General Psychiatry, 53, 159-168.
11. Merikangas, K. R. & Angst, J. (1995) Comorbidity and social phobia: evidence from clinical, epidemiologic, and genetic studies. European Archives of Psychiatry and Clinical Neurosciences, 244, 297-303.
12. OECD [Centre for Educational Research and Innovation] (1996) Education at a Glance Analysis, vol. 68. Paris: Organization for Economic Cooperation and Development.
13. Schneier, F. R., Johnson, J., Hornig, C. D., et al (1992) Comorbidity and morbidity in an epidemiologic sample. Archives of General Psychiatry, 49, 282-288.
14. _, Garfinkel, R., Kennedy, B., et al (1996) Ondansetron in the treatment of panic disorder. Anxiety, 2, 199-202.
15. Shear, M. K. & Beidel, D. C. (1998) Psychotherapy in the overall management for social anxiety disorder. Journal of Clinical Psychiatry, 59 (suppl. 17), 39-46.
16. Sheehan, D. (1983) The Anxiety Disease, pp. 148-149. New York: Scribner.
17. _, Lecrubier, Y., Sheehan, K. H., et al (1998) The Mini-International Neuropsythiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59 (suppl. 20), 22-33.
18. Stein, M. B., Liebowitz, M. R., Lydlard, R. B., et al (1998) Paroxetine treatment of generalised social phobia. A randomised, double-blind, placebo-controlled study. Journal of the American Medical Association, 280, 708-713.
19. Van Ameringen, M., Mancini, C. & Streiner, D. (1994) Sertraline in social phobia. Journal of Affective Disorders, 31, 141-145.
20. Van Vliet, I. M., den Boer, J. A. & Westenberg, H. G. M. (1994) Psychopharmacological treatment of social phobia; a double-blind, placebo-controlled study with fluvoxamine. Psychopharmacology (Berlin), 115, 128-134.
21. Wacker, H. R., Müllejans, R., Klein, K. H., et al (1992) Identification of cases of anxiety disorders and affective disorders in the community according to ICD-10 and DSM III-R by using the Composite International Diagnostic Interview (CIDI). International Journal of Methods in Psychiatric Research, 2, 91-100.
22. Watson, P. & Friend, R. (1969) Measurement of social-evaluative anxiety. Journal of Consulting and Clinical Psychology, 33, 448-457.
23. Weillor, E., Bisserbe, J.-C., Boyer, P., et al (1996) Social phobia in general hearth care. An unrecognised undertreated disabling disorder. British Journal of Psychiatry, 168, 169-174.
24. Wittchen, H.-U. & Beloch, E. (1996) The impact of social phobia on quality of life. International Clinical Psychopharmacology, 11 (suppl. 3), 15-23.